PRECISION MEDICINE MEANS ACTIONABLE INSIGHTS AND RANKED TARGETED DRUG TREATMENTS

CureMatch provides oncologists with clear, accessible, predictive treatment analysis to equip them with actionable knowledge tailored for each unique case.

Personalized Combination Therapy® treatment options for your cancer.

CureMatch is the trusted partner oncologists, NGS labs — and their patients — rely upon for the most advanced targeted Precision Medicine treatment options.

Leverage our advanced proprietary algorithms and extensive curation of a deep swath of genomic, historical, and your personal data; resulting in customized ranking and scoring of genomically matched combination treatments for consideration.

HOW DOES IT WORK?

Your doctor takes a sample of your cancer/blood and sends it in for genomic sequencing to find the mutations causing your cancer. The sequencing will be performed by a 3rd party service provider.


Tissue/Liquid Biopsy Procedure


CureMatch uses its software platform to analyze your genetic information and compare it with our large database of information from medical experts, other patients, clinical trials, and published data.


CureMatch Database Matching Analysis


Factoring in millions of drug combinations and cancer treatment results, CureMatch generates an analysis for your oncologist, matching Personalized Combination Therapy® options for your cancer.


We Rank Your Treatment Options


Your oncologist reviews your CureMatch Analysis and recommends a customized treatment plan. You and your oncologist begin cancer treatment using the latest approved targeted treatments available today.


You Choose a Treatment Plan


YOUR PERSONALIZED COMBINATION THERAPY ANALYSIS

It would take days for your oncologist to sort through the latest FDA approved drugs and decide what combinations of drugs could provide the best outcomes based on your genomic results. CureMatch provides a clear report layout of ranked combination drug therapies targeting your cancer at the genomic level regardless of the diagnosed ‘type’ of cancer. This report is designed to provide the concise actionable knowledge and insights your oncologist or care team needs to make the best decisions for your upcoming cancer drug treatment.